Our study corroborates previous reports, showing that cases harbouring CACNA1A variants typically present with ID/GDD, early-onset progressive ataxia, progressive cerebral atrophy, epilepsy, severe brain edema, coma, stroke-like presentations, and movement disorders. Here, CACNA1A is linked to Global developmental delay.